A new variety of Kentucky bluegrass has been commercially released by researchers at Washington State University. "Matchless," developed from another bluegrass variety called "Kenblue," offers seed ...
The Cherokee Nation’s first-come, first-served approach to heirloom seeds is being replaced with a random draw when the ...
SEED Therapeutics Inc. has announced that its molecular glue therapy, ST-01156, has been granted Rare Pediatric Disease and ...
Seed Therapeutics Inc.’s ST-01156 has been awarded orphan drug designation for the treatment of Ewing sarcoma as well as rare pediatric disease designation by the FDA.
After the holidays, I find it easy to slide into the winter doldrums, as I anticipate the long nippy weeks before the spring.